Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Budesonide/formoterol/duloxetine/xylometazoline

Rhinitis medicamentosa, reversible cerebral vasoconstriction syndrome and recurrent thunderclap headaches: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Pham H, et al. Recurrent thunderclap headaches from reversible cerebral vasoconstriction syndrome associated with duloxetine, xylometazoline and rhinitis medicamentosa. CMAJ: Canadian Medical Association Journal 192: E1403-E1406, No. 45, 9 Nov 2020. Available from: URL: http://doi.org/10.1503/cmaj.201234 Pham H, et al. Recurrent thunderclap headaches from reversible cerebral vasoconstriction syndrome associated with duloxetine, xylometazoline and rhinitis medicamentosa. CMAJ: Canadian Medical Association Journal 192: E1403-E1406, No. 45, 9 Nov 2020. Available from: URL: http://​doi.​org/​10.​1503/​cmaj.​201234
Metadaten
Titel
Budesonide/formoterol/duloxetine/xylometazoline
Rhinitis medicamentosa, reversible cerebral vasoconstriction syndrome and recurrent thunderclap headaches: case report
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-88009-5

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Cyclophosphamide